References
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
- Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi:10.1016/S0140-6736(20)30154-9
- Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi:10.1016/S0140-6736(20)30251-8
- Yang Y, Peng F, Wang R, et al. The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun. 2020;109:102434. doi:10.1016/j.jaut.2020.102434
- International CSG. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(1):1. doi:10.1038/s41564-019-0652-x
- Lai -C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.105924
- Gebru AA, Birhanu T, Wendimu E, et al. Global burden of COVID-19: situational analysis and review. Hum Antibodies. 2021;29(2):139–148. doi:10.3233/HAB-200420
- Mboussou F, Impouma B, Farham B, et al. Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020. Epidemiol Infect. 2021;149:1–21.
- Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971. doi:10.1056/NEJMc2001468
- McFee DRB. COVID-19 medical management including World Health Organization (WHO) suggested management strategies. Dis Mon. 2020;66(9):101068. doi:10.1016/j.disamonth.2020.101068
- World Health Organization. Clinical management of severe acute respiratory infection ( SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization; 2020.
- Son KB, Lee TJ, Hwang SS. Disease severity classification and COVID-19 outcomes, Republic Of Korea. Bull World Health Organ. 2021;99(1):62–66. doi:10.2471/BLT.20.257758
- Nkengasong JN, Mankoula W. Looming threat of COVID-19 infection in Africa: act collectively, and fast. Lancet. 2020;395(10227):841–842. doi:10.1016/S0140-6736(20)30464-5
- Iroulo LC, Boateng O. African States Must Localise Coronavirus Response. 2020.
- Dahab M, van Zandvoort K, Flasche S, et al. COVID-19 control in low-income settings and displaced populations: what can realistically be done? Health in Humanitarian Crises Centre; 2020. Available from: https://www.lshtmacUK/research/centers/health-humanitarian-crises-centre/news/102976. Accessed May 20, 2022.
- Tesfaye M. Federal democratic republic of Ethiopia ministry of science and higher education; 2020.
- Ayenew B. Challenges and opportunities to tackle COVID-19 spread in Ethiopia. J PeerScientist. 2020;2(2):e1000014.
- Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. Int J Infect Dis. 2020;94:44–48. doi:10.1016/j.ijid.2020.03.004
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
- Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667–673. doi:10.1016/j.jiph.2020.03.019
- Parasher A. COVID-19: current understanding of its pathophysiology, clinical presentation, and treatment. Postgrad Med J. 2021;97(1147):312–320. doi:10.1136/postgradmedj-2020-138577
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793. doi:10.1001/jama.2020.12839
- World Helath Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected Interim guidance; 2020.
- Liu D, Cui P, Zeng S, et al. Risk factors for developing into critical COVID-19 patients in Wuhan, China: a multicenter, retrospective, cohort study. EClinicalMedicine. 2020;25:100471. doi:10.1016/j.eclinm.2020.100471
- Abrahim SA, Tessema M, Ejeta E, et al. Median duration and factors that influence the duration of symptom resolution in COVID‐19 patients in Ethiopia: a follow‐up study involving symptomatic cases. Lifestyle Med. 2021;2:4. doi:10.1002/lim2.46
- Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006
- Alene KAGY, Fetene DM. COVID-19 in Ethiopia: a geospatial analysis of vulnerability to infection, case.severity, and death. BMJ Open. 2021;11(2):e044606. doi:10.1136/bmjopen-2020-044606
- Abraha HE, Gessesse Z, Gebrecherkos T, et al. Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia. Int J Infect Dis. 2021;105:776–783. doi:10.1016/j.ijid.2021.03.037
- Huh K, Lee R, Ji W, et al. Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: a matter of sexual dimorphism? Diabetes Res Clin Pract. 2020;170:108515. doi:10.1016/j.diabres.2020.108515
- Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A brief-review of the risk factors for covid-19 severity. Rev Saude Publica. 2020;54:60. doi:10.11606/s1518-8787.2020054002481
- Bastug A, Bodur H, Erdogan S, et al. Clinical and laboratory features of COVID-19: predictors of severe prognosis. Int Immunopharmacol. 2020;88:106950. doi:10.1016/j.intimp.2020.106950
- Cai Q, Chen F, Wang T, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392–1398. doi:10.2337/dc20-0576
- Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639–645. doi:10.1016/j.jinf.2020.03.019
- Li J, Chen Z, Nie Y, Ma Y, Guo Q, Dai X. Identification of symptoms prognostic of COVID-19 severity: multivariate data analysis of a case series in Henan Province. J Med Internet Res. 2020;22(6):e19636. doi:10.2196/19636
- Gallo marin B, Aghagoli G, Lavine K, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31(1):1–10. doi:10.1002/rmv.2146
- Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130(4):304–309. doi:10.20452/pamw.15272
- Figliozzi S, Masci PG, Ahmadi N, et al. Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10):e13362. doi:10.1111/eci.13362
- Leulseged TW, Abebe KG, Hassen IS, et al. COVID-19 disease severity and associated factors among Ethiopian patients: a study of the millennium COVID-19 care center. PLoS One. 2022;17(1):e0262896. doi:10.1371/journal.pone.0262896
- Li J, He X, Yuan Y, et al. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Am J Infect Control. 2021;49(1):82–89. doi:10.1016/j.ajic.2020.06.008
- Sharma J, Rajput R, Bhatia M, Arora P, Sood V. Clinical predictors of COVID-19 severity and mortality: a perspective. Front Cell Infect Microbiol. 2021;11:674277. doi:10.3389/fcimb.2021.674277